Rare diseases
Investigational molecules
Locations
Study of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk
BelgiumLong-term safety and effectiveness study of leniolisib for patients with primary immunodeficiency and immune system problems
SpainA Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder
BelgiumA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
FranceTesting sublingual immunotherapy with dermatophagoides pteronyssinus extract for adults with moderate to severe house dust mite allergy
GermanyTesting IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis
BulgariaA Study of Inhaled Fexlamose for Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease
BulgariaStudy of Sildenafil for Men with Erectile Dysfunction to Evaluate Their Ability to Safely Decide on Using This Medication Independently
PolandA study of immune system response in adults who develop shingles after receiving recombinant herpes zoster vaccine to understand vaccine protection
BelgiumA study testing zimberelimab, domvanalimab, and sacituzumab govitecan for patients with PD-L1 positive advanced triple-negative breast cancer
SpainLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
BelgiumA study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
